Literature DB >> 17885920

Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum.

Shin-ichiro Yasuda1, Takahiro Miyazaki, Kouji Munechika, Masami Yamashita, Yoshitaka Ikeda, Akihito Kamizono.   

Abstract

We attempted to determine natural agonists of GPR39 in fetal bovine serum (FBS). FBS was conditioned to extract peptides and fractionated by two types of HPLC. The activity of each fraction was monitored by intracellular calcium mobilization. Then the purified active ingredient was analyzed by inductively coupled plasma mass spectrometry. In this fashion, Zn2+ ion was identified as an agonist of GPR39, though no peptidergic molecules were found. The calcium-mobilizing activity of Zn2+ was not abolished by pertussis toxin but was by a phospholipase C (PLC) inhibitor, U73122, indicating that the activity of GPR39 is mediated through the Gqalpha -PLC pathway. In addition, Zn2+ also activated mouse and rat GPR39, showing that the function of GPR39 as a Zn2+ receptor is conserved across species. This study is the first exploration of GPR39 agonists in FBS and indicates that GPR39 functions as a Gq-coupled Zn2+-sensing receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885920     DOI: 10.1080/10799890701506147

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  32 in total

Review 1.  GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.

Authors:  Petra Popovics; Alan J Stewart
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.261

2.  Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair.

Authors:  Haleli Sharir; Anna Zinger; Andrey Nevo; Israel Sekler; Michal Hershfinkel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 3.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

Review 4.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Authors:  Stefan Peukert; Richard Hughes; Jill Nunez; Guo He; Zhao Yan; Rishi Jain; Luis Llamas; Sarah Luchansky; Adam Carlson; Guiqing Liang; Vidya Kunjathoor; Mike Pietropaolo; Jeffrey Shapiro; Anja Castellana; Xiaoping Wu; Avirup Bose
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

6.  Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).

Authors:  Xufen Yu; Xi-Ping Huang; Terry P Kenakin; Samuel T Slocum; Xin Chen; Michael L Martini; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2019-08-01       Impact factor: 7.446

7.  Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Authors:  Seiji Sato; Xi-Ping Huang; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2016-10-17       Impact factor: 4.436

8.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

9.  G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction.

Authors:  Birgitte Holst; Kristoffer L Egerod; Chunyu Jin; Pia Steen Petersen; Mette Viberg Østergaard; Jacob Hald; A M Ejernaes Sprinkel; Joachim Størling; Thomas Mandrup-Poulsen; Jens J Holst; Peter Thams; Cathrine Orskov; Nils Wierup; Frank Sundler; Ole D Madsen; Thue W Schwartz
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

10.  Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis.

Authors:  Tamara Perez-Rosello; Charles T Anderson; Francisco J Schopfer; Yanjun Zhao; David Gilad; Sonia R Salvatore; Bruce A Freeman; Michal Hershfinkel; Elias Aizenman; Thanos Tzounopoulos
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.